Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that Institutional Shareholder Services (“ISS”), a leading independent provider of proxy research and vote recommendations to the investment community, has recommended that Tilray shareholders vote “FOR” the Company's proposals at Tilray's Special Meeting of Stockholders (the “Special Meeting”) to

Leading Independent Proxy Advisory Firm ISS Recommends Tilray Shareholders Vote “FOR” All Proposals at Tilray's Upcoming Special Meeting

After consolidating over the past month, is Canadian cannabis company Tilray ready to breakout? Optimism is building for TLRY stock to have another, more sustainable, move.

Now Below Its June Range, Tilray Stock Looks Ready for the Next Leg Up

HEXO Corp

SNDL Inc.

As COVID-19 safety measures begin to slowly lift and more people are getting vaccinated, many industries are beginning to blossom. For the cannabis industry, in particular, this could mean an improved third quarter (compared to the second quarter) as restrictions began to ease in June, according to Cantor Fitzgerald's Pablo Zuanic.

Tilray, Aurora, Sundial, Hexo Q2 Market And Sales Trends, Cantor Fitzgerald Projects Stronger Q3

Flora Growth Corp

Innovative Industrial Properties

Amplify Alternative Harvest ETF

ETFMG 2X Daily Alternative Harvest ETF

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

Cannabis Industry Movers and Shakers This Week

Pot stocks are in the midst of a downtrend, but some are just giving back a bit of this year's gains.

Why Tilray and Other Cannabis Stocks Are Moving Down This Week

Aurora Cannabis

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

The Cannabis Growth Portfolio is the premier research service in the cannabis sector. Nearly 40 states have already legalized medical cannabis, and I expect more dominoes to fall over the next 10 years.

Launching The Cannabis Growth Portfolio: The Generational Buying Opportunity In Cannabis

Cannabis stocks tend to hibernate during the summer and giants Canopy Growth Corporation (NASDAQ:CGC) and Tilray, Inc. (NASDAQ:TLRY) have lulled into a sleepy sideways action. The sideways action came after a months-long downtrend after Canopy Growth and Tilray climbed in unison and reached highs of $56.50 and $67, respectively, on Feb. 10.

Tilray, Canopy Growth Options Traders Place Their Bets

Tilray is embarking on a push to educate more German doctors about the benefits of prescribing medical cannabis, as the weed giant seeks to cement its dominance in the highly-profitable European medical market.

Cannabis Watch: Tilray marks milestone German weed harvest and launches medical prescriptions drive

TLRY stock may be trading in one of the most saturated and competitive markets, but the new normal could be a benefactor. The post Why Tilray Might Be Looking Forward to the New Normal appeared first on InvestorPlace.

Why Tilray Might Be Looking Forward to the New Normal

An analyst at investment bank Jefferies loves marijuana stocks -- just not these marijuana stocks.

Why Canopy Growth, Hexo, and Tilray Stocks All Tumbled Today

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) finalized its first harvest of medical cannabis grown in Germany via its German subsidiary Aphria RX GmbH.  This is the company's first medical cannabis harvest under European Good Manufacturing Practices standard at its state-of-the-art 6,000 square-meter indoor grow facility in Neumünster, Germany.

Tilray's First Harvest And Distribution Of Medical Cannabis In Germany Successfully Completed

Tilray Inc. said its Germany-based subsidiary Aphria RX GmbH has completed the first successful harvest of medical cannabis, which was cultivated in Germany, for distribution to pharmacies. Tilray's stock rose 0.4% in premarket trading.

Tilray completes first harvest of medical cannabis for distribution at German pharmacies

Aphria

NEW YORK & NEUMÜNSTER, Germany--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ | TSX: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that its wholly-owned subsidiary in Germany, Aphria RX GmbH, has completed the first successful harvest of medical cannabis cultivated in Germany for distribution to German pharmacies. The medical cannabis harvest is the first cultivated under European Good Manufacturing Practices (EU GMP) standard at Tilray's state

Tilray's Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany

Cronos Group

Image Provided By Photo Stock Editor With the global legal marijuana market projected to reach $70.6 billion by 2028, more and more entrepreneurs and investors are looking for opportunities to get a foothold in this emerging industry. The specific applications and consumer trends that will take off in the coming years remains to be seen, but one of the most future-proof ways to  enter the cannabis industry is to get in on the cultivation side.

Indoor, Outdoor or Greenhouse: What to Look for in Different Cannabis Growing Properties

2 Top Canadian Marijuana Stocks To Watch This Month The post The Battle Of 2 Top Canadian Marijuana Stocks In July appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

The Battle Of 2 Top Canadian Marijuana Stocks In July

GrowGeneration Corp

Coffee Holding

Village Farms International

22nd Century Group

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry continues to shape up in 2021.

Pot Stock Roundup: Apple Enters the Fray

Anheuser-Busch InBev

Heineken NV

Altria

Constellation Brands

Molson Coors Brewing

Just because you can doesn't mean you should.

Maybe These Beverage Giants Should Have Stayed Away From Cannabis Drinks

Canadian Marijuana Stocks To Add To Your July Watchlist The post Best Canadian Marijuana Stocks To Buy? 2 To Watch In July appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy? 2 To Watch In July

Shares of Nasdaq-listed cannabis companies such as Tilray Inc. (NASDAQ:TLRY), Sundial Growers Inc. (NASDAQ:SNDL) and Aurora Cannabis Inc. (NASDAQ:ACB) have emerged as favorites of retail investors this year and continue to trend on Reddit's r/WallStreetBets forum, which has 10.6 million members and is known for short squeezes. Here's a comparative take on which retail-favorite cannabis stock gave the best returns in the first half of 2021.

Sundial Vs. Tilray Vs.

The Alternative Harvest exchange traded fund is up a healthy 38% year-to-date at $20.63. Over the past year, the ETF has risen 59%, outpacing broader stock markets.

3 Best Canadian Marijuana Stocks to Buy for the Upside Potential

While TLRY stock has now drawn attention from the Reddit crowd, insider selling makes banking on social media a tough proposition. The post Reddit's Relationship With Tilray May Not Be Lasting Love appeared first on InvestorPlace.

Reddit's Relationship With Tilray May Not Be Lasting Love

Cannabis giant Tilray, Inc. (NASDAQ:TLRY) announced on Wednesday that its SweetWater Brewing Company has launched its first Canadian craft cannabis brew in the US in collaboration with Canada's Broken Coast Cannabis Ltd. The tasty craft beer, Broken Coast BC Lager,  is the result of a collaboration between the Atlanta-based SweetWater –  acquired by Aphria Inc. (TSX:APHA) (NASDAQ:APHA) in November prior to the merger with Tilray – and Canada's leading craft cannabis brand under Tilray's portfolio in British Columbia.

Tilray Has Beer: Craft Cannabis Brew Coming Soon To US Bars and Stores

NEW YORK--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that its SweetWater Brewing Company (“SweetWater”) has launched a new product collaboration with Canada's leading craft cannabis brand Broken Coast Cannabis Ltd. (“Broken Coast”), a brand under the Tilray portfolio based in British Columbia and geared toward the premium cannabis market. “Broken Coast BC Lager1 ” is the first cross-bran

Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) released a proxy statement with an open letter from the company's CEO Irwin D. Simon, in which he called on shareholders to support a proposal to be discussed up at the upcoming annual shareholder meeting.

Tilray CEO Seeks Shareholder Approval For Dilution To Fuel Its Acquisitions Plans

Tilray Inc. (NASDAQ:TLRY) has convened a meeting with shareholders on 29th July seeking board approval on several strategic initiatives. The company wants to raise more capital by increasing authorised common stock to finance future acquisitions.

As Tilray targets more strategic acquisitions, is it time to buy?

News for Tilray Brands Stock (TLRY)